Development of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface Antigen

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 8, 2009, Pages 889-893

  Tong, Myron John ^a,b   Nguyen, Michael Ong ^b   Tong, Lori Terese ^b   Blatt, Lawrence Mitchell ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

^c AliosBiopharma   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ABDOMINAL RADIOGRAPHY; ADOLESCENT; ADULT; AGED; ARTICLE; ASIAN; CAUCASIAN; CHILD; CLINICAL ARTICLE; ECHOGRAPHY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PLASMA CLEARANCE; PRESCHOOL CHILD; SCHOOL CHILD;

ABDOMEN; ADOLESCENT; ADULT; AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 67949103443     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2009.04.012     Document Type: Article

References (26)

1. Wu T.T., Hsu H.C., Chen D.S., et al. Clearance of hepatitis B surface antigen (HBsAg) after surgical resection of hepatocellular carcinoma. J Hepatol 4 (1987) 45-51
2. Liaw Y.F., Sheen I.S., Chen T.J., et al. Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study. Hepatology 13 (1991) 627-631
3. Chu C.M., and Liaw Y.F. HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up. Hepatology 45 (2007) 1187-1192
4. Sampliner R.F., Hamilton F.A., Iseri O.A., et al. The liver histology and frequency of clearance of the hepatitis B surface antigen (HBsAg) in chronic carriers. Am J Med Sci 277 (1979) 17-22
5. Feinman S.V., Berris B., Cooter N., et al. Results of long-term prospective study of the hepatitis B surface antigen (HBsAg) carrier state. Hepatogastroenterology 29 (1982) 58-61
6. de Franchis R., Meucci G., Vecchi M., et al. The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 118 (1993) 191-194
7. Da Silva L.C., Madruga C.L., Carrilho F.J., et al. Spontaneous hepatitis B surface antigen clearance in a long-term follow-up study of patients with chronic type B hepatitis. Lack of correlation with hepatitis C and D virus superinfection. J Gastroentrol 31 (1996) 696-701
8. Fattovich G., Giustina G., Sanchez-Tapias J., et al. Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. Am J Gastroenterol 93 (1998) 896-900
9. McMahon B.J., Holck P., Bulkow L., et al. Serologic and clinical outcomes of 1536 Alaska native chronically infected with hepatitis B virus. Ann Intern Med 135 (2001) 759-768
10. Yuen M.F., Wong D.K., Sablon E., et al. HBsAg seroclearance in chronic hepatitis B in the Chinese: virology, histological and clinical aspects. Hepatology 39 (2004) 1694-1701
11. Arase Y., Ikeda K., Suzuki Y., et al. Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B. Am J Med 119 (2006) 71-16
12. Ahn S.H., Park Y.N., Park J.Y., et al. Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance. J Hepatol 42 (2005) 188-194
13. Adachi H., Kaneko S., Matsushita E., et al. Clearance of HBsAg in seven patients with chronic hepatitis B. Hepatology 16 (1992) 1334-1337
14. Huo T.I., Wu J.C., Lee P.C., et al. Seroclearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 28 (1999) 231-236
15. Arase Y., Suzuki F., Suzuki Y., et al. Long-term presence of HBV in the sera of chronic hepatitis B patients with HBsAg seroclearance. Intervirology 50 (2007) 161-165
16. Loriot M., Marcellin P., Walker F., et al. Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg. J Hepatol 27 (1997) 251-258
17. Pollicino T., Squadrito G., Cerenzia G., et al. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 126 (2004) 102-110
18. Chen C.M., Karayiannis P., Flower M.J., et al. Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum. Hepatology 5 (1985) 431-434
19. Liaw Y.F., Chen Y.C., Sheen I.S., et al. Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology 126 (2004) 1024-1029
20. Tong M.J., Blatt L.M., Kao J.-H., et al. Precore/basal core promoter mutants and HBV DNA levels as predictors for liver deaths and hepatocellular carcinoma. World J Gastroenterol 12 (2006) 6620-6626
21. Tong M.J., Hsien C., Hsu L., et al. Treatment recommendation for chronic hepatitis B: an evaluation of current guidelines based on a natural history in the United States. Hepatology 48 (2008) 1070-1078
22. Kim J.H., Lee J.H., Park S.J., et al. Factors associated with natural seroclearance of hepatitis B surface antigen and prognosis after seroclearance: a prospective follow-up study. Hepatogastroenterology 55 (2008) 578-581
23. Ruiz-Moreno M., Otero M., and Millan A. Clinical and histological outcome after hepatitis B e antigen to antibody seroconversion in children with chronic hepatitis B. Hepatology 29 (1999) 572-575
24. Lok A.S.F., and McMahon B.J. Chronic hepatitis B. Hepatology 45 (2007) 507-539
25. Yuen M.F., Wong D.K.H., Fund J., et al. HBsAg seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Gastroenterology 135 (2008) 1192-1199
26. Tong M.J., Weiner J.M., Ashcavai M.W., et al. A comparative study of hepatitis B viral markers in the family members of Asian and non-Asian patients with hepatitis B surface antigen-positive hepatocellular carcinoma and with chronic hepatitis B infection. J Infect Dis 140 (1979) 506-512